CAMBRIDGE, Mass. & SEOUL, South Korea–(BUSINESS WIRE)–Shaperon Inc. grabbed the spotlight at BioFuture 2023 as it confidently graced the stage, delivering a compelling compa… Read More
SAN FRANCISCO — A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials.
PARTNER 3 a… Read More
MADRID — Treatment with tisotumab vedotin (Tivdak) significantly extended overall survival (OS) compared with chemotherapy in patients with recurrent or metastatic cervical cancer… Read More
A four-drug regimen for newly diagnosed high-risk multiple myeloma induced high rates of sustained minimal residual disease (MRD) negativity regardless of transplant status, a German resea… Read More
In 2021, the global gene therapy market was estimated to be worth $1.55 billion USD. The market is expected to increase from US$ 1.85 billion in 2022 to US$ 10.1 billion by 2032, at an 18.5%… Read More
More than 40% of patients with muscle-invasive bladder cancer (MIBC) avoided immediate cystectomy after achieving a clinical complete response (cCR) with a chemoimmunotherapy combination… Read More
Achieve Optimal Health with the Orthopathy Diet!
By Tom Seest
Can the Orthopathy Diet Help You Achieve Optimal Health?
At HowDoYouLose, we save you time and resources by curating relevant in… Read More
Vision for Generative Artificial Intelligence in Medical Affairs
Download the Article
Endorsed by members of the MAPS Executive Consortium:
Randy Brown, Global Lead | Respirator… Read More
Lab-grown meat is buzzy for a reason. The ick factor is palpable, and the benefits of scaling alternatives to factory farming are enormous. Yet, plenty of other crucial corners of agricultur… Read More
[Research Report] The glioma treatment market revenue was valued at US$ 4,139.0 million in 2022 and the glioma treatment market size are projected to reach US$ 8,291.3 million by 2… Read More
Ravulizumab (Ultomiris), a terminal complement C5 inhibitor, did not improve functional status and survival in patients with amyotrophic lateral sclerosis (ALS), the phase III CHAMPION-ALS… Read More
Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and… Read More
A new study has repurposed an existing blood cancer drug, using it to eliminate dormant HIV-infected cells that can cause the infection to reactivate when suppressive antiretroviral treatmen… Read More